The strength of Michigan's infant life sciences industry depends ultimately on the availability of an educated workforce, the quality of collaboration among leading research institutions, and access to plenty of venture capital.
That's essentially what some of the more important people behind the scenes of the state's biotech business told attendees at a recent forum. The forum was sponsored by the Business Review and the Core Technology Alliance and, among others, speakers included Michigan House Speaker Andy Dillon, from Redford Township, David Van Andel, CEO of the Van Andel Institute, and Birgit Klohs, president of the Right Place, Inc.
"The money is a key factor," Van Andel said. "It's going to take lone rangers doing it. The people who are willing to see it through, who are willing to take the second mortgage, that's why the risk takers get the big rewards."
Click
here to read the full story.
Source: Michigan Technology News
Enjoy this story?
Sign up for free solutions-based reporting in your inbox each week.